FindTrial
Sign In

A Clinical study on Maantha maathirai(Internal) and Sanni thiri pugai(External) for Autism

Phase-II â?? Non Randomized Clinical Study on Maantha sanni (Autism spectrum disorder) with the evaluation of Siddha trail drug Maantha maathirai(Internal) and Sanni thiri pugai(External) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056528
Enrollment
40
Registered
2023-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Interventions

Intervention1: Maantha maathirai(Internal) and Sanni thiri pugai(External): Maantha maathirai ¼(199.5mg) to ½(399mg) tablet with luke warm water twice a day for 48 days and External fumigation of S

Sponsors

Government Siddha medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children have lack of eye contact Lack of response Repetitive or restricted behaviour Unawareness of natural urges Acquired speech or lost it Unusual sensitive to sensory stimuli

Exclusion criteria

Exclusion criteria: Children above 12 years Children below 2 years Severe and recurrent Seizures ADHD Cerebral palsy Infantile hemiplegia Congenital anomalies

Design outcomes

Primary

MeasureTime frame
Primary outcome is assessed by reduction of the clinical symptoms before & after treatment Timepoint: 48 days—

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing the safety parameters before & after treatmentTimepoint: 48 days—

Countries

India

Contacts

Public ContactDr D Sivasankari

Government Siddha Medical College Chennai

mahema.siddha@gmail.com9894325360

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026